An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss.

Wang, Zi-Long; Zheng, Jia-Rui; Yang, Rui-Feng; Huang, Lin-Xiang; Chen, Hong-Song; Feng, Bo

Wang, Zi-Long; Zheng, Jia-Rui; Yang, Rui-Feng; Huang, Lin-Xiang; Chen, Hong-Song; Feng, Bo.

Afiliación

Wang ZL; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
Zheng JR; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
Yang RF; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
Huang LX; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
Chen HS; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.
Feng B; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.

J Clin Transl Hepatol ; 11(1): 197-206, 2023 Feb 28.

Article en En | MEDLINE | ID: mdl-36406318

Palabras clave

Biomarker; Chronic hepatitis B; Complete cure; Functional cure; HBsAg; Hepatitis B virus; Immunoassay

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Idioma: En Revista: J Clin Transl Hepatol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google